One sentence summary: This study shows that clinical isolates of Pseudomonas aeruginosa can induce in parallel cytotoxicity and modulation of cytokine balance in the host cells, depending on the virulence factors they produce.
effects were prevented by a specific caspase-1 inhibitor. Flagellar motility was not correlated with cytotoxicity or IL-1β release. No apoptosis was detected. Thus, T3SS cytotoxicity is accompanied by a modification in cytokine balance for P. aeruginosa clinical isolates that do not express ExoU.
Keywords: type three secretion system; inflammasome; ExoS; ExoU; TNF-alpha; flagellin Pseudomonas aeruginosa is a major cause of healthcareassociated infections, with severe morbidity and high mortality. Its capacity to develop antibiotic resistance limits therapeutic options, leading to treatment failures. Moreover, the P. aeruginosa genome encodes several virulence factors and environmental sensor-regulator systems, allowing it to adapt to hostile environments, induce tissue injury and control inflammatory reactions. Studying cellular responses to the virulence factors expressed by clinical isolates is critical in order to evaluate the usefulness of combining antibiotics with specific inhibitors of these virulence mechanisms or immunomodulators.
Type III secretion system (T3SS) is a major virulence factor in P. aeruginosa, associated with poor clinical outcome and high morbidity in acute infections. T3SS enables bacteria to inject exotoxins into the host cell cytoplasm (Sawa 2014) . Among them, the phospholipase A2 ExoU causes rapid cell death by disrupting membrane integrity, while ExoS prevents bacterial internalization and induces cell necrosis or apoptosis (Okuda, Hanabusa and Gotoh 2014) . Beside these toxin-dependent effects, T3SS also delivers flagellin or T3SS rod proteins into the mammalian cytosol, inducing secretion of IL-1β and IL-18 (Miao et al. 2008 (Miao et al. , 2010 . Contrary to TNF-α, IL-1β and IL-18 secretion requires two signals (Miao et al. 2008) , namely (i) Toll-like receptor (TLR) activation (inducing transcription and translation of the proforms of these cytokines) and (ii) NOD-like receptors (NLR) (activating caspase-1 and inducing cytokine processing and secretion, leading to pyroptotic cell death). Pseudomonas aeruginosa T3SS specifically activates NLRC4 (NLR family, CARD domain containing 4; also known as Ipaf) inflammasome. In the case of P. aeruginosa infection, IL-1β release seems essentially related to this process, as it is totally inhibited in nlrc4 -/-macrophages (Faure et al. 2014) .
Bacteria-induced inflammasome activation and subsequent IL-1β and IL-18 release have been generally considered as protective (Sutterwala et al. 2007; Cai et al. 2012 ). Yet, in the case of P. aeruginosa infections, these processes are rather deleterious, contributing to increased tissue injury and impaired bacterial clearance (Schultz et al. 2002; Cohen and Prince 2013; Faure et al. 2014) . Moreover, flagellum-mediated motility has been suggested to also modulate inflammasome response and IL-1β release (Patankar et al. 2013) . At this stage, however, these concepts have been studied only with reference strains and mutants thereof expressing or not specific proteins from the T3SS or the flagellum.
In this context, this study aimed at (i) examining whether T3SS positive-clinical isolates collected from patients suffering from acute infections are also able to induce IL-1β release and (ii) determining whether the IL-1β production is related to toxin expression or flagellar motility, and correlates with the degree of cytotoxicity induced. TNF-α release was also followed as a control because its production is unrelated to inflammasome activation (Akira and Takeda 2004) . Human THP-1 monocytes were used as model of phagocytic cells capable to activate NLRC4 inflammasome in response to T3SS. Table S1 (Supporting Information) shows the strains under study. They include (i) 20 clinical isolates from acute infections retrospectively collected in four Belgian hospitals, (ii) three reference strains, namely PA103 (expressing ExoU), PAO1 and CHA (expressing ExoS, ExoT, ExoY) and (iii) mutants with deletions in genes coding for T3SS toxins (PA103 UT; CHA STY), proteins from the translocation apparatus (PA103 pcrV; CHA popB/popD) or T3SS regulon (CHA ExsA). These strains were characterized for the expression of genes encoding toxins, translocation apparatus or flagellin, and for swarming motility in 0.3% LB agar plate. Their serotype and genetic relatedness were determined in order to check for sufficient diversity within the collection (Table S1 and Fig. S1 , Supporting Information).
If excluding negative controls (PA103 pcrV, CHA popBD, CHA ExsA), the other strains could be classified in two groups (Table S1 , Supporting Information), namely (i) 8 clinical isolates plus PA103 expressing ExoU, ExoT and the translocation apparatus (T3SS+ ExoU+) and (ii) 12 clinical isolates plus PAO1, CHA, CHA STY and PA103 UT expressing the translocation apparatus but not the ExoU toxin (T3SS+ExoU−). ExoS+ strains were thus more represented in this collection than ExoU+ strains, and none of them expressed both toxins, as generally observed (Garey et al. 2008; El-Solh et al. 2012) . No toxin was expressed in PA103 UT and CHA STY. exoU, exoS and exoT expression levels were highly variable, ranging from 283 to 1% of the values measured in reference strains. Flagellin expression and swimming motility were variable, with no correlation between flagellin expression and motility (Table S2 , Supporting Information). THP-1 monocytes were then incubated with each of these isolates. Cytotoxicity was assessed by measuring lactate dehydrogenase (LDH) release in the culture supernatant. IL-1β and TNF-α were quantified in supernatants by ELISA. As IL-1β is released in response to caspase-1 activation, cells were also preincubated with 40 μM of the specific caspase-1 inhibitor Ac-YVAD-cmk (N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone, Sigma-Aldrich, Saint-Louis, MO). Incubation time was set at 5 h based on preliminary experiments demonstrating that cytotoxicity was essentially mediated by T3SS in these conditions (see values in Fig. 1 ; cytotoxicity high for PA103; moderate for CHA and largest difference with that of CHA ExsA). Figure 1 shows data for each individual strain (left) or for T3SS+ strains grouped according to the expression of ExoU (right). Considering reference strains, PA103 induced a massive LDH release but a low release of cytokines, which was not affected by Ac-YVAD-cmk. CHA was less cytotoxic but induced a significantly larger release of IL-1β (reversed by Ac-YVADcmk) but not of TNF-α. Remarkably, PA103 UT and CHA STY showed a profile similar to that of CHA despite the fact they did not express any toxin but still the translocation apparatus. PA103 pcrV, CHA popBD and CHA ExsA were not cytotoxic and induced minimal IL-1β release. All together, these data confirm the role of T3SS apparatus rather than toxins in this by guest on January 12, 2016 http://femspd.oxfordjournals.org/ Downloaded from were incubated with each of these isolates (10 bacteria/cell) during 5 h. Cytotoxicity was assessed by measuring the release of LDH into the culture supernatant using the cytotoxicity detection kit PLUS (Roche, Basel, Switzerland). IL-1β and TNF-α were quantified in supernatants using a commercially available ELISA kit ( by guest on January 12, 2016
http://femspd.oxfordjournals.org/ Downloaded from process (Miao et al. 2008) . PA103 UT and CHA STY induced a larger IL-1β release than their parental strains, which is compatible with the previously demonstrated inhibitory effect of the toxins on inflammasome activation (Sutterwala et al. 2007; Galle et al. 2008) . Moving to clinical isolates, all T3SS+ExoU+ isolates behaved as PA103, while all T3SS+ExoU− isolates caused only 20-50% LDH release and a commensurate release of IL-1β but not of TNF-α. Again Ac-YVAD-cmk significantly reduced cytotoxicity and IL-1β release for T3SS +ExoU− isolates, with no influence on TNF-α release. Inflammasome activation by T3SS+ ExoU− isolates was confirmed in western blot by the presence of the active form of caspase-1 and of IL-1β in cell culture supernatants, which was not observed for T3SS+ExoU+ isolates (Fig. S2 , Supporting Information). As the latter isolates were more cytotoxic, we also checked that inflammasome activation did not occur earlier.
To this effect, we followed LDH and IL-1β release over time and showed that they were never inhibited by Ac-YVADcmk (Fig. S3, Supporting Information) . In parallel, we looked for the presence of apoptotic cells vs necrotic cells over 5 h of incubation using representative ExoU+ or ExoU− strains and found that cell death was associated with membrane permeabilization (necrosis or pyroptosis) but not apoptosis whatever the incubation time (Fig. S4 , Supporting Information), as previously demonstrated for CHA (Dacheux et al. 2000) .
Potential relationships between toxin or flagellin expression, motility and cytotoxicity or cytokine release were systematically looked for by appropriate statistical analysis of the correlations between pairs of parameters (Table S2 , Supporting Information). Globally, a highly significant correlation was observed between IL-1β and TNF-α secretion in the absence of Ac-YVADcmk (Fig. 1G) . Moreover, the release of IL-1β but not that of TNF-α was correlated with cytotoxicity, whether cells were pretreated or not with Ac-YVAD-cmk, but only for T3SS+ExoU-strains ( Fig. 1H/I ). Other correlations were not significant.
The main conclusion from this study is that cytotoxicity exerted by T3SS-positive clinical isolates from acute infections is correlated with IL-1β release for strains that do not express ExoU. The high cytotoxicity of T3SS+ExoU+ isolates could rely on the phospholipase activity of the toxin, which may cause cell lysis before any mechanism of cell response could be activated (Sato and Frank 2004) . Low IL-1β levels detected after 5 h incubation correspond to its proform released in the medium after cell death, which explains why Ac-YVAD-cmk did not prevent this process. Conversely, cytotoxicity and IL-1β release induced by T3SS+ExoU− strains are largely inhibited by Ac-YVAD-cmk, being consecutive to caspase-1 activation (probably related to NLRC4 inflammasome). Notably also, we did not observe an inverse correlation between toxin expression levels and IL-1β secretion, in spite of the described inhibitory effect of the toxin on inflammasome activation (Sutterwala et al. 2007; Galle et al. 2008) .
We also noticed a correlation between TNF-α and IL-1β release induced by the whole collection. This probably results from a simultaneous production of TNF-α and proIL-1β via TLR activation, because the correlation is lost in the presence of Ac-YVAD-cmk that prevents proIL-1β maturation. We can neither exclude a cytotoxicity related to indirect caspase-1 activation via caspase-11 activation in response to LPS (Kayagaki et al. 2013) .
On the contrary, we were unable to demonstrate any correlation between flagellin expression level (Miao et al. 2008; Cohen and Prince 2013) and flagellar motility (Patankar et al. 2013) or between motility and cytotoxicity or cytokine release.
Secretion of ExoU is considered as a marker of high virulence (Schulert et al. 2003) , but expression of ExoU or ExoS has been both associated with poor clinical outcome (El-Solh et al. 2012) . We show here that the pattern of cytokines expressed by the host cells in response to T3SS depends, at least in vitro, on whether the strain expresses or not ExoU.
Thus, pending for animal studies aiming at confirming these observations and further exploring the consequences of this cytokine dysbalance, our data suggest that inhibiting T3SS functionality by immunotherapy or small compounds (Kline et al. 2012 ) may be more appropriate than blocking specifically toxins. This work opens the door to the study of innovative therapeutic strategy to be combined with antibiotics during acute pseudomonal infections.
SUPPLEMENTARY DATA
Supplementary data are available at FEMSPD online. g Relative quantification of mRNA levels (ratio between the number of copies for the gene of interest and for rpsL as housekeeping gene). Bacteria were resuspended in LB medium containing 5 mM EDTA and 20 mM MgCl2 and grown from OD620nm 0.1 to 0.8 with aeration and constant shaking (300 rpm). Total RNA was extracted using the InviTrap® Spin Cell RNA Mini Kit (Stratec Molecular, Berlin, Germany) and reverse transcribed using the Transcriptor first strand kit (Roche, Basel, Switzerland) according to the manufacturer's instructions. RNA purity was checked for the absence of contaminating DNA prior to reverse transcription by PCR amplification of a fragment of the rpsL gene. Primers were designed based on the published genome sequences of PAO1 or of P. aeruginosa NCGM2.S1 for fliC-a (not expressed by PAO1). Amplification reactions were performed in the presence of Sybr Green IQ supermix (Bio-Rad Laboratories, Hercules, CA), using a iCycler iQ Single-Color Real-Time-PCR Detection System (MyiQ TM real time PCR software; Bio-Rad), using rpsL to normalize transcript levels.
Supplementary Table 2
Correlation between the different parameters for all strains, or within a group of strains (T3SS+ ExoU+ or T3SS+ ExoU-). All data points (cells incubated or not with Ac-YVAD-cmk) were used for these analyses.
For each combination of parameters, the coefficient of determination r² and the Pearson correlation coefficient (rp) were calculated. Values in red point to correlations that are significant; those in italics, to correlations considering both cells pretreated or not with the caspase-1 inhibitor Ac-YVAD-cmk. NA: not applicable. The figures show the percentage identity among strains. A threshold criterion of 95% similarity was used, corresponding to two or less peak differences in the whole electrophoresis pattern.
PA103 and T3SS+ExoU+ clinical isolates induced the release of the proforms of caspase-1 and IL-1β in the supernatant, probably as a consequence of ExoU-induced membrane permeabilization, but not the activation of these 2 proteins, excluding inflammasome activation as a mechanism of cell death induced by these strains. CHA and T3SS+ExoU-clinical isolates induced not only both the release of the proforms of caspase-1 and IL-1β in the supernatant, but also of their active forms, strongly suggesting that cell death occurs for these strains by pyroptosis as a consequence of inflammasome activation. Note that the release of both pro-and mature forms of these proteins was very low for PA103ΔpcrV or CHAΔpopBD, demonstrating the role of the functionality of T3SS in inflammasome activation and subsequent cytotoxicity. Cytotoxicity was assessed by measuring the release of lactate dehydrogenase (LDH) into the culture supernatant using the cytotoxicity detection kit PLUS (Roche, Basel, Switzerland). IL-1β was quantified in supernatants using a commercially available ELISA kit (R&D systems, Minneapolis, MN).
Values are means ± SD of two experiments performed in triplicates and expressed as the percentage of LDH release or IL-1β release for the nine strains compared to the maximal value recorded at 5 h in the absence of capsase-1 inhibitor. Statistical analyses: p > 0.05 when comparing data obtained in the absence of in the presence of inhibitor over time; two-way ANOVA with Bonferroni post-test.
Cytotoxicity and Il-1β released increased over time but were not reduced by the caspase-1 inhibitor Ac-YVADcmk, suggesting that inflammasome activation is not a cause of cell death induced by these strains, even for short incubation times were cytotoxicity is moderate. All strains caused time-dependent necrosis/pyroptosis but not apoptosis; toxicity was higher and occurred earlier for T3SS+ExoU+ strains than for T3SS+ExoU-strains; it was minimal for T3SS-CHAΔExsA.
